Iterum Therapeutics PLC (ITRM) — Tangible Net Worth Ratio
Iterum Therapeutics PLC (ITRM) has a Tangible Net Worth Ratio of 87.4% as of September 2023. This metric is calculated by deducting intangible assets ($432.00K) from net assets ($3.43 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See ITRM net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Iterum Therapeutics PLC Tangible Net Worth Ratio (2016–2022)
This chart shows how Iterum Therapeutics PLC's Tangible Net Worth Ratio has changed across 5 annual periods from 2016 to 2022. As of September 2023, the ratio stands at 87.4%, reflecting net assets of $3.43 Million with intangible assets of $432.00K USD. See ITRM days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Iterum Therapeutics PLC (2016–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Iterum Therapeutics PLC from 2016 to 2022, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Iterum Therapeutics PLC market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 93.9% | $28.00 Million | $1.72 Million | $66.83 Million | ▲ +0.7 pp |
| 2021 | 93.2% | $50.23 Million | $3.44 Million | $91.51 Million | ▼ -6.8 pp |
| 2018 | 100.0% | $71.62 Million | $0.00 | $97.87 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $39.49 Million | $0.00 | $46.76 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $22.67 Million | $0.00 | $26.92 Million | — |